Format

Send to

Choose Destination
Biochim Biophys Acta. 2016 May;1862(5):992-1007. doi: 10.1016/j.bbadis.2015.11.010. Epub 2015 Nov 27.

Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.

Author information

1
Department of Physiology and the Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio. Electronic address: galvanv@uthscsa.edu.
2
Department of Biochemistry, University of Texas Health Science Center at San Antonio.

Abstract

Aging is the strongest known risk factor for Alzheimer's disease (AD). With the discovery of the mechanistic target of rapamycin (mTOR) as a critical pathway controlling the rate of aging in mice, molecules at the interface between the regulation of aging and the mechanisms of specific age-associated diseases can be identified. We will review emerging evidence that mTOR-dependent brain vascular dysfunction, a universal feature of aging, may be one of the mechanisms linking the regulation of the rate of aging to the pathogenesis of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.

KEYWORDS:

Aging; Alzheimer's; Geroscience; MTOR; Neurovascular aging; Target of rapamycin

PMID:
26639036
PMCID:
PMC6762019
DOI:
10.1016/j.bbadis.2015.11.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center